Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu

Safety Study of Combined Azithromycin, Ivermectin and Albendazole for Trachoma and Lymphatic Filariasis (AZIVAL2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01903057
Recruitment Status : Withdrawn (As of November 2013, the security situation in rural Northern Mozambique is no longer suitable for this clinical trial.)
First Posted : July 19, 2013
Last Update Posted : May 22, 2014
Information provided by (Responsible Party):
Huub Gelderblom MD, PhD, MPH, Emory University